Unither Pharmaceuticals
Unither Pharmaceuticals is a leading French manufacturer specializing in contract manufacturing services for the pharmaceutical and healthcare industries. The company focuses on producing a variety of dosage forms, including sterile unit doses, non-sterile liquids, and solid and semi-solid medications. Utilizing advanced technologies such as blow-fill-seal (BFS) and liquid stick-packs, Unither also offers regulatory expertise, galenic development, and analytical services. This comprehensive range of services enables clients to efficiently outsource the manufacturing of their pharmaceutical products, solidifying Unither's position as a world leader in the contract manufacturing sector.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
5 past transactions
Carragelose
Acquisition in 2024
Carragelose is a biotechnology company that develops and markets a unique, nature-based antiviral compound. Its flagship product is a moisturizing eye film designed to soothe dry eyes while also preventing and treating viral respiratory illnesses. The company's innovative solution leverages the power of natural ingredients to inhibit viral replication and transmission, offering a safe and effective way for individuals to protect themselves from respiratory infections.
BIOPHTA
Seed Round in 2024
BIOPHTA has developed a novel ophthalmic platform that delivers medication continuously through non‑invasive topical inserts. The system uses a mini‑tablet that turns into a hydrogel upon contact with the eye, creating a sustained‑release vehicle for drugs. This approach offers a more effective and less invasive alternative to conventional eye drops and injections for both anterior and posterior eye diseases, improving long‑term disease management.
Curecall
Corporate Round in 2021
Curecall is a healthcare technology company that specializes in a conversational text messaging platform for remote patient monitoring. It primarily serves healthcare professionals, particularly ophthalmologists, by automating patient follow-ups through SMS, including visual acuity tests and quality of life assessments. The platform provides real-time access to patient data through a secure, user-friendly dashboard, enhancing clinical trial management and improving patient care.
Nanjing Ruinian Best Pharmaceutical
Acquisition in 2020
Nanjing Ruinian Best Pharmaceutical Co., Ltd. is a pharmaceutical manufacturer based in Nanjing, China, incorporated in 2004. The company specializes in the development and production of various pharmaceutical dosage forms, including tablets, granules, eye drops, capsules, and bulk drugs. Originally named Nanjing Ruinian Shuangke Pharmaceutical Co., Ltd., it rebranded in 2006. As of August 2020, Nanjing Ruinian Best Pharmaceutical operates as a subsidiary of Unither Pharmaceuticals SAS, focusing on delivering a diverse range of pharmaceutical products to meet healthcare needs.
Curecall
Corporate Round in 2020
Curecall is a healthcare technology company that specializes in a conversational text messaging platform for remote patient monitoring. It primarily serves healthcare professionals, particularly ophthalmologists, by automating patient follow-ups through SMS, including visual acuity tests and quality of life assessments. The platform provides real-time access to patient data through a secure, user-friendly dashboard, enhancing clinical trial management and improving patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.